Back to search
FDAFDA · Food and drugs·Recall number D-1446-2016

buPROPion Hydrochloride Extended Release Tablets USP (SR) 150 mg Rx Only 60 tablets Distributed by Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol 389-350 Gujarat India ---- NDC 47335-737-86

Published July 27, 2016 · Recall initiated: June 27, 2016

Summary

FDA records drug Class III recall D-1446-2016, published July 27, 2016 and initiated June 27, 2016. Recalling firm: Sun Pharmaceutical Industries, Inc.; Status: Terminated; Reported quantity: 16,085 bottles; Lot: Lot JKN3477A, exp 07/2016. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email if BUPROPION HYDROCHLORIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
BUPROPION HYDROCHLORIDE
Manufacturer
Sun Pharmaceutical Industries, Inc.
Distributor
Nationwide
UPC
0347335738865
Lot
Lot JKN3477A, exp 07/2016
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was buPROPion Hydrochloride Extended Release Tablets USP (SR) 150 mg Rx Only 60 tablets Distributed by Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol 389-350 Gujarat India ---- NDC 47335-737-86 recalled?

Yes. FDA published recall D-1446-2016 on July 27, 2016. Reported hazard: Failed Dissolution Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: BUPROPION HYDROCHLORIDE. UPC: 0347335738865.